Key Takeaways
- ADAMA achieved a 25% increase in adjusted EBITDA to $587 million for full year 2025, with EBITDA margin improving from 11.3% to 14.5%.
- The company turned adjusted net income positive to $28 million in 2025, recovering from a $206 million loss in 2024.
- Free cash flow improved by $51 million to $269 million for the full year, reflecting enhanced operational discipline under the Fight Forward transformation plan.
- ADAMA launched 139 new products in 2025, including innovative herbicides EDAPTIS and PULIMAISI, and registered multiple differentiated solutions across global markets.
- President and CEO Gaël Hili emphasized that the results demonstrate success of the company's two-year business transformation focused on cost competitiveness and commercial capabilities.
ADAMA Delivers Strong Financial Turnaround
ADAMA Ltd. (SHE: 000553) reported significant improvements in key financial metrics for the fourth quarter and full year ended December 31, 2025. The agricultural solutions company achieved a 25% increase in adjusted EBITDA to $587 million for the full year, while turning adjusted net income positive to $28 million compared to a $206 million loss in 2024.
Fourth quarter results showed adjusted EBITDA up 14% to $157 million, with gross margin improving from 25.2% to 30.6% year-over-year. Despite an 8% decline in quarterly sales to $1,026 million, the company demonstrated enhanced profitability through cost optimization initiatives.
“ADAMA's 2025 financial results show important improvements in key financial metrics including continued growth in EBITDA and its margin; increased cash generation; significantly reduced reported net loss; and an adjusted net profit. These encouraging successes reflect the strong foundation we have built over the past two years through our Fight Forward transformation plan, where we focused on improving cost competitiveness, enhancing our commercial capabilities, and advancing our innovation portfolio and pipeline,” said Gaël Hili, President and CEO of ADAMA.
